Showing results (11-20 of 151) with videos related to
Sort By:
Pageof 16
Cardiovascular Drug Reviews|August 22, 2003
Development of novel water-soluble phytostanol analogs: disodium ascorbyl phytostanyl phosphates (FM-VP4): preclinical pharmacology, pharmacokinetics and toxicologyAgatha W K Ng, Tatjana Lukic, P Haydn Pritchard, et al.Cardiovascular Drug Reviews|December 4, 2003
Stem cell therapy in ischemic heart diseaseJulia N E Sunkomat, Mohamed A GaballaCardiovascular Drug Reviews|July 7, 2007
Cardiovascular effects of tibolone: a selective tissue estrogenic activity regulatorRoxana Campisi, Fernando D MarengoCardiovascular Drug Reviews|February 7, 2002
AH-1058: a novel cardioselective Ca2+ channel blockerA Takahara, A Sugiyama, R Yoshimoto, et al.Cardiovascular Drug Reviews|February 7, 2002
Pharmacology of SCH00013: a novel Ca2+ sensitizerM Endoh, H Sugawara, M MineshimaCardiovascular Drug Reviews|October 25, 2002
Cardiovascular effects of androgensWolfgang Weidemann, Hartmut HankeCardiovascular Drug Reviews|August 3, 2001
Carvedilol: molecular and cellular basis for its multifaceted therapeutic potentialJ Cheng, K Kamiya, I KodamaCardiovascular Drug Reviews|April 15, 2006
CGS 35601, a triple inhibitor of angiotensin converting enzyme, neutral endopeptidase and endothelin converting enzymeBruno Battistini, Philippe Daull, Arco Y JengCardiovascular Drug Reviews|April 15, 2006
Ximelagatran, the new oral anticoagulant: would warfarin survive the challenge?Shaker A Mousa, Hikmat N Abdel-RazeqCardiovascular Drug Reviews|May 4, 2005
Colesevelam: potential uses for the newest bile resinKaren L Steinmetz, Kristine S SchonderPageof 16